COVID-19 and Respiratory System Disorders: Current Knowledge, Future Clinical and Translational Research Questions.
Arterioscler Thromb Vasc Biol
; 40(11): 2586-2597, 2020 11.
Article
in English
| MEDLINE | ID: covidwho-1015731
ABSTRACT
The severe acute respiratory syndrome coronavirus-2 emerged as a serious human pathogen in late 2019, causing the disease coronavirus disease 2019 (COVID-19). The most common clinical presentation of severe COVID-19 is acute respiratory failure consistent with the acute respiratory distress syndrome. Airway, lung parenchymal, pulmonary vascular, and respiratory neuromuscular disorders all feature in COVID-19. This article reviews what is known about the effects of severe acute respiratory syndrome coronavirus-2 infection on different parts of the respiratory system, clues to understanding the underlying biology of respiratory disease, and highlights current and future translation and clinical research questions.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Respiration
/
Respiratory Distress Syndrome
/
Respiratory Insufficiency
/
Coronavirus Infections
/
Translational Research, Biomedical
/
Betacoronavirus
/
Lung
Type of study:
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Limits:
Animals
/
Humans
Language:
English
Journal:
Arterioscler Thromb Vasc Biol
Journal subject:
Vascular Diseases
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS